Scienture Holdings, Inc (SCNX)
NCM · Common · CUSIP 89846A207
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SCNX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
89846A207 (prev. 89846A108 )
Market Cap
Micro Cap
Previous Symbol
MEDS (changed 8/28/2024)
Previous Name
Trxade Health, Inc.
Business: Scienture Holdings, Inc is a health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the U.S.
Notes: Feb 13. 2020 -- The Reverse Stock Split became effective at 12:01 a.m. Eastern Standard Time on February 13, 2020 (the “Effective Date”), whereupon the shares of common stock began trading on a split-adjusted basis. In connection with the Reverse Stock Split and the Uplisting (discussed below under Item 8.01), the Company’s shares of common stock will trade on the Nasdaq Capital Market under the symbol “MEDS” and will trade under a new CUSIP Number, 89846A207. On the Effective Date, the total number of shares of the Company’s common stock held by each stockholder were converted automatically into the number of whole shares of common stock equal to (i) the number of issued and outstanding shares of common stock held by such stockholder immediately prior to the Reverse Stock Split, divided by (ii) 6.

Company Contact

CEO
Suren Ajjarapu
CFO
Howard Doss
Headquarters
6308 Benjamin Rd, Suite 708 , Tampa FL 33634
Phone
800-261-0281
Investor Relations
info@scienture.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »